Magnus G. Jespersen
- Infectious Diseases top 10%
- Antimicrobial Resistance in Staphylococcus 2
-
- Streptococcal Infections and Treatments 7
- Neonatal and Maternal Infections 2
-
- Infective Endocarditis Diagnosis and Management 4
-
- Genomics and Phylogenetic Studies 3
- RNA and protein synthesis mechanisms 2
-
- Plant Pathogenic Bacteria Studies 2
-
- Microbial Inactivation Methods 2
- Co-authors
- Mark R. DaviesMark J. WalkerStephan BrouwerDavid M. P. De OliveiraTania Rivera-HernándezBodie F. CurrenNichaela Harbison-PriceSteven Y. C. Tong
- Cited by
- Infectious DiseasesPublic Health, Environmental and Occupational HealthClinical Biochemistry
- Journals
- Nucleic Acids Research (1 paper)Nature Communications (1 paper)Nature Reviews Microbiology (2 papers)
- Partner nations
- AustraliaDenmarkUnited Kingdom
In The Last Decade
Magnus G. Jespersen
12 papers receiving 266 citations
Hit Papers
Peers
Comparison fields: 5 of 64
- Infectious Diseases 130
- Public Health, Environmental and Occupational Health 183
- Clinical Biochemistry 32
- Endocrinology 15
- Microbiology 13
Countries citing papers authored by Magnus G. Jespersen
This map shows the geographic impact of Magnus G. Jespersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Magnus G. Jespersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Magnus G. Jespersen more than expected).
Fields of papers citing papers by Magnus G. Jespersen
This network shows the impact of papers produced by Magnus G. Jespersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Magnus G. Jespersen. The network helps show where Magnus G. Jespersen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Magnus G. Jespersen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 3 | |
| 6 | Pathogenesis, epidemiology and control of Group A Streptococcus infectionbreakdown → | 2023 | 146 |
| 7 | 2023 | 6 | |
| 8 | 2022 | 5 | |
| 9 | 2022 | 1 | |
| 10 | 2022 | 3 | |
| 11 | 2022 | 20 | |
| 12 | 2022 | 1 | |
| 13 | 2020 | 39 | |
| 14 | 2020 | 44 |
About Magnus G. Jespersen
Magnus G. Jespersen is a scholar working on Biotechnology, Public Health, Environmental and Occupational Health and Molecular Medicine, having authored 14 papers that have together received 273 indexed citations. Recurring topics across this work include Streptococcal Infections and Treatments (7 papers), Infective Endocarditis Diagnosis and Management (4 papers), Genomics and Phylogenetic Studies (3 papers), Plant Pathogenic Bacteria Studies (2 papers), Microbial Inactivation Methods (2 papers), Neonatal and Maternal Infections (2 papers), RNA and protein synthesis mechanisms (2 papers) and Antimicrobial Resistance in Staphylococcus (2 papers). The work is most often cited by research in Infectious Diseases (130 citations), Public Health, Environmental and Occupational Health (183 citations) and Clinical Biochemistry (32 citations). Magnus G. Jespersen has collaborated with scholars based in Australia, Denmark and United Kingdom. Frequent co-authors include Mark R. Davies, Mark J. Walker, Stephan Brouwer, David M. P. De Oliveira, Tania Rivera-Hernández, Bodie F. Curren, Nichaela Harbison-Price, Steven Y. C. Tong, Jake A. Lacey and Amanda J. Cork. Their work appears in journals such as Nucleic Acids Research, Nature Communications and Nature Reviews Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.